TTF-1 positive atypical carcinoid of the epiglottis mimicking medullary thyroid carcinoma
暂无分享,去创建一个
J. Ruf | J. Pfeiffer | H. Fuellgraf | K. Michalski | P. Kurz
[1] W. Oyen,et al. Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[2] J. Hunt,et al. Differential Diagnosis in Neuroendocrine Neoplasms of the Larynx. , 2017, Advances in anatomic pathology.
[3] Douglas B. Evans,et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. , 2015, Thyroid : official journal of the American Thyroid Association.
[4] B. Plaat,et al. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta‐analysis of 436 reported cases , 2015, Head & neck.
[5] N. Stathatos,et al. Clinical review: Ectopic cervical thyroid carcinoma--review of the literature with illustrative case series. , 2011, The Journal of clinical endocrinology and metabolism.
[6] M. Hirsch,et al. Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid , 2004, Modern Pathology.
[7] B. Wenig,et al. Moderately differentiated neuroendocrine carcinoma of the larynx: A clinicopathologic study of 54 cases , 1988, Cancer.
[8] L. Barnes,et al. Pathology and genetics of head and neck tumours , 2005 .
[9] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .